As eries of pharmaceutically relevant small molecules and biopharmaceuticals bearing aliphatic carboxamides have been successfully labeled with carbon-13. Key to the successo ft his novel carbon isotopel abeling technique is the observation that 13 C-labeled Ni II -acyl complexes, formed from a 13 CO insertion step with Ni II -alkyl intermediates, rapidly react in less than one minute with 2,2'-dipyridyl disulfide to quantitatively form the corresponding 2-pyridyl thioesters.E ither the use of 13 C-SilaCOgen or 13 C-COgen allows for the stoichiometric additiono fi sotopically labeled carbon monoxide. Subsequento ne-pot acylation of as eries of structurally diverse amines provides the desired 13 C-la-beled carboxamides in good yields. Asingle electron transfer pathway is proposedb etween the Ni II -acyl complexes and the disulfide providing ar eactive Ni III -acyl sulfide intermediate, which rapidly undergoes reductivee limination to the desired thioester.B yf urthero ptimization of the reactionp arameters, reaction times down to only 11 min were identified, opening up the possibility of exploring this chemistry for carbon-11i sotope labeling. Finally,t his isotope labeling strategyc ould be adapted to the synthesis of 13 C-labeled liraglutide and insulind egludec, representing two antidiabetic drugs.